Related Experiment Video
Updated: Jun 8, 2026

08:17
Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure
Published on: August 25, 2017
Excess lung function decline in gold miners following pulmonary tuberculosis
J Ross1, R I Ehrlich, E Hnizdo
1Mailman School of Public Health, Columbia University, New York, USA.
Thorax
|September 28, 2010
Summary
Treated pulmonary tuberculosis (TB) significantly accelerates lung function decline in gold miners, leading to greater loss in forced expiratory volume in 1 second (FEV1) and forced vital capacity (FVC). Early TB detection is crucial to mitigate these long-term respiratory effects.
Area of Science:
- Occupational Health
- Respiratory Medicine
- Epidemiology
Background:
- Pulmonary tuberculosis (TB) is a significant global health concern.
- Long-term lung function loss following TB treatment is not well-documented, especially with premorbid data.
- South African gold miners represent a high-risk population for both TB and occupational lung diseases.
Purpose of the Study:
- To investigate the association between treated pulmonary tuberculosis and subsequent lung function decline.
- To quantify the excess loss in lung function (FEV1 and FVC) attributable to TB.
- To highlight the need for recognizing and managing the long-term respiratory sequelae of TB.
Main Methods:
- Retrospective cohort study of South African gold miners.
- Comparison of lung function (PFT) in 185 miners treated for TB versus 185 age-matched controls without TB.
- Analysis of lung function decline (FEV1, FVC) over a 4-year follow-up period, controlling for confounders.
Main Results:
- Pulmonary TB was associated with an excess annual loss of 40.3 ml/year in FEV1 and 42.7 ml/year in FVC.
- Lung function loss was more pronounced with severe or later-stage TB presentation.
- Breathlessness was twice as common in TB cases.
Conclusions:
- Treated pulmonary TB leads to significant, long-term lung function impairment.
- Early TB detection and management are critical to reduce respiratory sequelae, especially in high-risk occupational settings.
- Preventive strategies, including dust control and TB prevention therapy, are essential to avert TB and its consequences.
Related Concept Videos
Pulmonary Tuberculosis II
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis I
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Tuberculosis
Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...
Pulmonary Tuberculosis III
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pneumothorax-II
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
